Angaben zur Quelle [Bearbeiten]
| Autor | M.E.C. Robbins, W. Zhao |
| Titel | Oxidative Stress and Radiation-Induced Late Normal Tissue Injury |
| Sammlung | Oxidative Stress and Neurodegenerative Disorders |
| Herausgeber | G. Ali Qureshi and S. Hassan Parvez |
| Ort | Amsterdam |
| Verlag | Elsevier |
| Jahr | 2007 |
| Seiten | 135-164 |
| ISBN | 0-444-52809-1 |
Literaturverz. |
no |
| Fußnoten | no |
| Fragmente | 1 |
Fragmente der Quelle:
| [1.] Iam/Fragment 003 13 - Diskussion Zuletzt bearbeitet: 2014-03-12 19:44:00 Graf Isolan | Fragment, Gesichtet, Iam, Robbins and Zhao 2007, SMWFragment, Schutzlevel sysop, Verschleierung |
|
|
|
| Untersuchte Arbeit: Seite: 3, Zeilen: 13-22 |
Quelle: Robbins and Zhao 2007 Seite(n): 135, Zeilen: 8-18 |
|---|---|
| Consequently, for most patients, cancer can be considered a chronic disease. The total radiation dose that can be administered safely to cancer patients is limited by the risk of complications arising in those normal tissues unavoidably included within the treatment volume. Of particular concern are the late effects that arise several months to years post irradiation. While improvements in radiation oncology such as intensity-modulated radiation therapy (IMRT) have led to a reduction in the dose of normal tissue irradiated, late effects remain a significant risk (Robbins and Zhao 2004). The National Cancer Institute has identified long-term survival from cancer as one of the new areas of public health emphasis, particularly studying adverse long-term or late effects of cancer and its treatment (National Cancer Institute’s Plans and Priorities for Cancer Research: http://plan.cancer.gov/public/survivor.htm).
Robbins ME, Zhao W (2004) Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 80:251-259 |
Consequently, for most patients, cancer can be considered a chronic disease. The total radiation dose that can be administered safely to cancer patients is limited by the risk of complications arising in those normal tissues unavoidably included within the treatment volume. Of particular concern are the late effects that can arise several months to years postirradiation. While improvements in radiation oncology such as intensity-modulated radiation therapy (IMRT) have led to a reduction in the volume of normal tissue irradiated, late effects remain a significant risk. The National Cancer Institute has identified long-term survival from cancer as one of the new areas of public health emphasis, particularly studying adverse long-term or late effects of cancer and its treatment (National Cancer Institute’s Plans and Priorities for Cancer Research). |
The names of the original authors are given in passing (though to a different article). Nothing has been marked as a citation although the wording is nearly identical. |
|